Indian pharma industry registers 5.3% YoY revenue growth in Dec 2021 : Ind-Ra
Ind-Ra expects revenue growth of over 12% in 2022.
Ind-Ra expects revenue growth of over 12% in 2022.
This service benefits pharmaceutical and fine chemical companies looking to optimise their reactions
10 implementation focused initiatives recommended to accelerate policy reforms, standardization of home care delivery services, and improve accessibility and affordability of care in tier II and tier III geographies
Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters
The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022
In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc
Flattish volume growth and subdued new launches were key factors for last month
The revolutionary new nano coating is easy to apply and rejects liquid-based contagions like COVID-19/SARS-CoV-2 and variants, influenzas, and rhinoviruses and is available via ready-to-use sprays or pre-treated air filters
2022 is going to be the year of opportunities and innovations from the medical industry in India
Scoliosis is a disorder of the spine, and its surgeries are generally done only in large hospitals in big cities.
Subscribe To Our Newsletter & Stay Updated